Metabolomics

Dataset Information

0

EMT alterations in the solute carrier landscape uncover SLC22A10/A15 imposed vulnerabilities in pancreatic cancer


ABSTRACT:

The involvement of membrane-bound solute carriers (SLCs) in neoplastic transdifferentiation processes is poorly defined. Here, we examined changes in the SLC landscape during epithelial-mesenchymal transition (EMT) of pancreatic cancer cells. We show that two SLCs from the organic anion/cation transporter family, SLC22A10 and SLC22A15, favor EMT via interferon (IFN) α and γ signaling activation of receptor tyrosine kinase-like orphan receptor 1 (ROR1) expression. In addition, SLC22A10 and SLC22A15 allow tumor cell accumulation of glutathione to support EMT via the IFNα/γ-ROR1 axis. Moreover, a pan-SLC22A inhibitor lesinurad reduces EMT-induced metastasis and gemcitabine chemoresistance to prolong survival in mouse models of pancreatic cancer, thus identifying new vulnerabilities for human PDAC.

INSTRUMENT(S): Liquid Chromatography MS - positive - reverse phase

SUBMITTER: Debasis Nayak 

PROVIDER: MTBLS1925 | MetaboLights | 2021-10-15

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
MTBLS1925 Other
FILES Other
a_MTBLS1925_LC-MS_positive_reverse-phase_metabolite_profiling-1.txt Txt
files-all.json Other
i_Investigation.txt Txt
Items per page:
1 - 5 of 7

Similar Datasets

2023-03-07 | GSE218698 | GEO
2024-09-02 | BIOMD0000000544 | BioModels
2024-09-02 | BIOMD0000000543 | BioModels
2020-09-11 | ST001492 | MetabolomicsWorkbench
2019-06-20 | GSE130567 | GEO
2019-06-12 | GSE120944 | GEO
2019-06-12 | GSE120943 | GEO
2019-06-12 | GSE120942 | GEO
2014-09-22 | GSE33527 | GEO
2012-01-25 | E-GEOD-28499 | biostudies-arrayexpress